Sanofi-Aventis S.A. ADR (SNY): Congress and insider trades
Who in Congress and inside the company traded SNY, when each filing appeared, and what buying after each one would have earned against the S&P 500.
Key Facts
- Sanofi-Aventis S.A. ADR (SNY) is a listed stock on NASDAQ.
- 5 members of Congress filed 6 buys and 5 sells of SNY, the latest published 2026-07-21 (21 July 2026).
- Insiders filed 1 open market buy worth $5.1M and 0 sells worth $0, the latest filed 2026-08-07 (7 August 2026).
- Across 5 scored buys, Congress averaged -6.7% against the S&P 500 (SPY) over the 90 days after disclosure, with 40% of them ahead of the index. That result is too few trades to draw a conclusion.
- Data as of 2026-09-29 (29 September 2026).
Congress trades in SNY
as of 2026-07-21| Filed | Member | Type | Size | Days to file | 90 day vs S&P |
|---|---|---|---|---|---|
| 21 Jul 2026 | Alan Armstrong (R-OK) | buy | 15K–50K | 113 | n/a |
| 10 Nov 2023 | Ro Khanna (D-CA) | buy | 1K–15K | 26 | -12.2% |
| 9 Oct 2023 | Ro Khanna (D-CA) | sell | 1K–15K | 28 | n/a |
| 7 Sep 2023 | Ro Khanna (D-CA) | sell | 1K–15K | 26 | n/a |
| 14 Aug 2023 | Daniel S. Goldman (D-NY) | sell | 15K–50K | 34 | n/a |
| 14 Jun 2023 | Ro Khanna (D-CA) | buy | 1K–15K | 31 | +3.5% |
| 10 May 2023 | Ro Khanna (D-CA) | buy | 1K–15K | 24 | -7.0% |
| 21 Mar 2023 | Daniel S. Goldman (D-NY) | sell | 1K–15K | 21 | n/a |
| 10 Mar 2023 | Ro Khanna (D-CA) | buy | 15K–50K | 26 | +1.1% |
| 7 Jul 2022 | Earl Blumenauer (D-OR) | buy | 15K–50K | 40 | -18.9% |
| 20 Apr 2022 | John Rutherford (R-FL) | sell | 1K–15K | 34 | n/a |
Nothing matches that search.
Insider trades in SNY
as of 2026-08-07| Filed | Insider | Type | Shares | Price | Value | 90 day vs S&P |
|---|---|---|---|---|---|---|
| 7 Aug 2026 | Sanofi | buy | 300,000 | $17.00 | $5.1M | n/a |
Nothing matches that search.
Related pages
Frequently asked questions
Who has bought SNY?
6 Congress buys by 5 members and 1 insider buy are on file. The tables on this page list every one.
Did buying SNY after a disclosure beat the market?
Across 5 scored buys, Congress averaged -6.7% against the S&P 500 (SPY) over the 90 days after disclosure, with 40% of them ahead of the index. That result is too few trades to draw a conclusion. A single stock is a small sample.
Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.
Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.